Crestline Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,559
| Closed | -$767K | – | 82 |
|
|
2024
Q4 | $767K | Sell |
13,559
-13,520
| -50% | -$765K | 0.03% | 460 |
|
|
2024
Q3 | $1.4M | Buy |
+27,079
| New | +$1.4M | 0.07% | 226 |
|
|
2019
Q3 | – | Sell |
-77,000
| Closed | -$3.49M | – | 83 |
|
|
2019
Q2 | $3.49M | Buy |
+77,000
| New | +$3.49M | 0.47% | 34 |
|
|
2018
Q3 | – | Sell |
-64,224
| Closed | -$3.55M | – | 159 |
|
|
2018
Q2 | $3.55M | Buy |
64,224
+18,940
| +42% | +$1.05M | 0.37% | 65 |
|
|
2018
Q1 | $2.86M | Sell |
45,284
-7,005
| -13% | -$443K | 0.36% | 38 |
|
|
2017
Q4 | $3.2M | Buy |
52,289
+11,889
| +29% | +$728K | 0.33% | 26 |
|
|
2017
Q3 | $2.58M | Buy |
+40,400
| New | +$2.58M | 0.36% | 46 |
|